Montelukast Prescribing at SOVEREIGN PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,581
Total Quantity
47.1K
NHS Cost
£2.3K
vs National Avg
+130.9%
SOVEREIGN PRACTICE prescribed 1,581 items of Montelukast over the last 12 months at a cost of £2,324 to the NHS. This is 130.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
143
Jun 2026
140
Jun 2026
152
Jun 2026
136
Jun 2026
135
Jun 2026
133
Jun 2026
124
Jun 2026
129
Jun 2026
119
Jun 2026
126
Jun 2026
119
Jun 2026
125
Prescribing Details
| Total Items | 1,581 |
|---|---|
| Total Quantity | 47,052 |
| Total NHS Cost | £2,324 |
| Presentations | 4 different forms |
| vs National Average | +130.9% |
Montelukast Prescribing Comparison
| This practice | 1,581 items |
|---|---|
| National average per practice | 685 items |
| Difference | +130.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.